Cite
HARVARD Citation
Sramek, J. et al. (2016). Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects. CNS neuroscience & therapeutics. pp. 404-412. [Online].